Tumor necrosis factor-α promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensivity reaction in the skin of borderline tuberculoid leprosy patients

Immunogenetics

Volumn 53, Issue 1, 2001, Pages 45-47

  Moraes, M O ^a   Duppre, N C ^a   Suffys, P N ^a   Santos, A R ^a   Almeida, A S ^a   Nery, J A C ^a   Sampaio, E P ^a   Sarno, E N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Leprosy; Mycobacteria; Polymorphism; Promoter; TNF

Indexed keywords

BCG VACCINE; INTERLEUKIN 10; LEPROMIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BCG VACCINATION; DELAYED HYPERSENSITIVITY; GENE FREQUENCY; GENOTYPE; GRANULOMATOSIS; HUMAN; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSAL REACTION; SPAIN;

DERMATITIS, ALLERGIC CONTACT; LEPROSY; LEPROSY, BORDERLINE; LEPROSY, TUBERCULOID; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM LEPRAE;

EID: 0035090042     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510000295     Document Type: Article

References (24)

1. The effect of thalidomide on BCG-induced granulomas in mice
2. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to human NRAMP1 gene in Vietnamese leprosy sibships
3. Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis
4. Polymorphism of the human TNF-α promoter - Random variation or functional diversity?
5. Tumor necrosis factor production in patients with leprosy
6. Variations in the NRAMP1 gene and susceptibility to tuberculosis
7. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy: A six-year follow-up study in Calcutta
8. Genetic epidemiology of the Mitsuda reaction in leprosy
9. Tumor necrosis factor alpha is pro-inflammatory in normal skin and modulates cutaneous adhesion molecule expression
10. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM)
11. The inducing role of tumor necrosis factor in the development of the bactericidal granulomas during BCG infection
12. Identification of an AP-2 element in the -323 to -285 region of the TNFα gene
13. The -308 tumor necrosis factor-α promoter polymorphism effects transcription
14. Effects of stimulus and cell type on the expression of the -308 tumor necrosis factor promoter polymorphism
15. Serial Mitsuda tests for identification of reactional tuberculoid and reactional borderline leprosy forms
16. Immunological cytokine correlates of protective immunity and pathogenesis of leprosy
17. Tumor necrosis factor (TNF) gene polymorphism influences TNFα production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
18. Differential effector and secretory functions of microglial cell lines derived from BCG-resistant and -susceptible congenic mouse strains
19. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum
20. Classification of leprosy according to immunity - A five group system
21. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages
22. Tumor necrosis factor promoter polymorphism (TNF2) seemed to protect against development of severe forms of leprosy in a pilot study in Brazilian patients
23. Gamma delta T cells in leprosy lesions
24. Genetics of tumor necrosis factor-α in autoimmune, infectious and neoplastic diseases